Infection Probability Score: A predictor of Clostridium difficile-associated disease onset in patients with haematological malignancy

被引:17
作者
Apostolopoulou, Eleni [2 ]
Raftopoulos, Vasilios [1 ]
Terzis, Konstantinos [3 ]
Elefsiniotis, Ioannis [2 ]
机构
[1] Cyprus Univ Technol, Dept Nursing, Mediterranean Res Ctr Publ Hlth & Qual Care, Nicosia, Cyprus
[2] Univ Athens, Dept Nursing, Athens, Greece
[3] Halkida Gen Hosp, Halkida, Greece
关键词
Infection probability score; Healthcare-associated infections; APACHE II; KARNOFSKY; Hematology; Clostridium difficile-associated disease; RISK-FACTORS; NOSOCOMIAL INFECTIONS; HOSPITALIZED-PATIENTS; APACHE-II; DIARRHEA; TOXIN; EPIDEMIOLOGY; CHEMOTHERAPY; COLITIS; SURVEILLANCE;
D O I
10.1016/j.ejon.2010.11.002
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: to assess the predictive power of three systems: Infection Probability Score, APACHE II and KARNOFSKY score for the onset of Clostridium difficile-associated disease (CDAD) in hematology-oncology patients. Methods and sample: A retrospective pilot surveillance survey was conducted in the hematology unit of a general hospital in Greece. Data were collected by using an anonymous standardised case-record form. The sample consisted of 102 hospitalized patients. Results: The majority of the patients (33.3%) suffered from acute myeloid leukemia. The cumulative incidence of CDAD was 10.8% and the incidence rate of C difficile associated diarrhea was 5 per 1000 patient-days (14.2 per 1000 patient-days at risk). Patients with CDAD had twofold higher time of mean length of hospital stay compared with patients without CDAD (38.82 +/- 23.88 vs 19.45 +/- 14.56 days). Additionally patients with CDAD had received a greater number of different antibiotics compared to those without CDAD (5.18 +/- 1.99 vs 2.54 +/- 2.13), suffered from diabetes, from non Hodgkin's lymphoma, had a statistically significant higher duration of neutropenia >= 3 days and had received antifungal treatment. The best cutoff value of IPS for the prediction of CDAD was 13 with a sensitivity of 45.5% and a specificity of 82.4%. Conclusions: IPS is an early diagnostic test for CDAD detection. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:404 / 409
页数:6
相关论文
共 50 条
  • [21] Changing Epidemiology of Clostridium difficile-Associated Disease during Stem Cell Transplantation
    Trifilio, Steven M.
    Pi, Judy
    Mehta, Jayesh
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (03) : 405 - 409
  • [22] Incidence and outcomes of Clostridium difficile-associated disease in hematopoietic cell transplant recipients
    Guddati, Achuta Kumar
    Kumar, Gagan
    Ahmed, Shahryar
    Ali, Muhammad
    Kumar, Nilay
    Hari, Parameswaran
    Venu, Nanda
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2014, 99 (06) : 758 - 765
  • [23] The burden of Clostridium difficile-associated disease following digestive tract surgery in Japan
    Yasunaga, H.
    Horiguchi, H.
    Hashimoto, H.
    Matsuda, S.
    Fushimi, K.
    JOURNAL OF HOSPITAL INFECTION, 2012, 82 (03) : 175 - 180
  • [24] Analyses of fluoroquinolones and Clostridium difficile-associated diarrhoea in tuberculosis patients
    Chang, K. C.
    Leung, C. C.
    Yew, W. W.
    Lam, F. M.
    Ho, P. L.
    Chau, C. H.
    Cheng, V. C. C.
    Yuen, K. Y.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2009, 13 (03) : 341 - 346
  • [25] Molecular Epidemiology of Clostridium difficile Strains in Children Compared with That of Strains Circulating in Adults with Clostridium difficile-Associated Infection
    Stoesser, Nicole
    Crook, Derrick W.
    Fung, Rowena
    Griffiths, David
    Harding, Rosalind M.
    Kachrimanidou, Melina
    Keshav, Satish
    Peto, Tim E.
    Vaughan, Alison
    Walker, A. Sarah
    Dingle, Kate E.
    JOURNAL OF CLINICAL MICROBIOLOGY, 2011, 49 (11) : 3994 - 3996
  • [26] Optimum Timing of Blood Tests for Monitoring Patients With Clostridium difficile-Associated Diarrhea
    Bhangu, Aneel
    Czapran, Adam
    Bhangu, Sonia
    Pillay, Devadas
    JOURNAL OF INVESTIGATIVE MEDICINE, 2010, 58 (04) : 621 - 624
  • [27] Clostridium difficile Infection and Limitations of Markers for Severity in Patients with Hematologic Malignancy
    Wang, Michael S.
    Evans, Charlesnika T.
    Rodriguez, Tulio
    Gerding, Dale N.
    Johnson, Stuart
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2013, 34 (02) : 127 - 132
  • [28] Hospital-Associated Clostridium difficile Infection: Is It Necessary to Track Community-Onset Disease?
    Dubberke, Erik R.
    McMullen, Kathleen M.
    Mayfield, Jennie L.
    Reske, Kimberly A.
    Georgantopoulos, Peter
    Warren, David K.
    Fraser, Victoria J.
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2009, 30 (04) : 332 - 337
  • [29] Predictors of mortality attributable to Clostridium difficile infection in patients with underlying malignancy
    Yoon, Young Kyung
    Kim, Min Ja
    Sohn, Jang Wook
    Kim, Hye Suk
    Choi, Yoon Ji
    Kim, Jung Sun
    Kim, Seung Tae
    Park, Kyong Hwa
    Kim, Seok Jin
    Kim, Byung Soo
    Shin, Sang Won
    Kim, Yeul Hong
    Park, Yong
    SUPPORTIVE CARE IN CANCER, 2014, 22 (08) : 2039 - 2048
  • [30] Clostridium difficile-associated disease in children with solid tumors
    Elio Castagnola
    Teresa Battaglia
    Roberto Bandettini
    Ilaria Caviglia
    Ivana Baldelli
    Marilina Nantron
    Cristina Moroni
    Alberto Garaventa
    Supportive Care in Cancer, 2009, 17